{"DataElement":{"publicId":"5580460","version":"1","preferredName":"Chronic Graft Versus Host Disease Lung Involvement Final Score","preferredDefinition":"Final score that represents the lung symptom and FEV1 scores associated with cGVHD (chronic Graft vs. Host Disease).","longName":"CGVHD_LUNG_FNL_SCR","context":"CCR","contextVersion":"1","DataElementConcept":{"publicId":"5040568","version":"1","preferredName":"Chronic Graft Versus Host Disease Lung Involvement","preferredDefinition":"A syndrome of immunologically mediated tissue damage that may occur following an allogeneic transplant, and may affect multiple organs with manifestations similar to autoimmune diseases. The onset is usually within three years of transplantation or immunologic manipulation._One of a pair of viscera occupying the pulmonary cavities of the thorax, the organs of respiration in which aeration of the blood takes place. As a rule, the right lung is slightly larger than the left and is divided into three lobes (an upper, a middle, and a lower or basal), while the left has two lobes (an upper and a lower or basal). Each lung is irregularly conical in shape, presenting a blunt upper extremity (the apex), a concave base following the curve of the diaphragm, an outer convex surface (costal surface), an inner or mediastinal surface (mediastinal surface), a thin and sharp anterior border, and a thick and rounded posterior border._To have a connection by participation or association or use; sharing in an activity or process.","longName":"5040566v1.0:2192548v1.0","context":"NHLBI","contextVersion":"1","ObjectClass":{"publicId":"5040566","version":"1","preferredName":"Chronic Graft Versus Host Disease Lung","preferredDefinition":"A syndrome of immunologically mediated tissue damage that may occur following an allogeneic transplant, and may affect multiple organs with manifestations similar to autoimmune diseases. The onset is usually within three years of transplantation or immunologic manipulation.:One of a pair of viscera occupying the pulmonary cavities of the thorax, the organs of respiration in which aeration of the blood takes place. As a rule, the right lung is slightly larger than the left and is divided into three lobes (an upper, a middle, and a lower or basal), while the left has two lobes (an upper and a lower or basal). Each lung is irregularly conical in shape, presenting a blunt upper extremity (the apex), a concave base following the curve of the diaphragm, an outer convex surface (costal surface), an inner or mediastinal surface (mediastinal surface), a thin and sharp anterior border, and a thick and rounded posterior border.","longName":"C4981:C12468","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Chronic Graft Versus Host Disease","conceptCode":"C4981","definition":"A syndrome of immunologically mediated tissue damage that may occur following an allogeneic transplant, and may affect multiple organs with manifestations similar to autoimmune diseases. The onset is usually within three years of transplantation or immunologic manipulation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Lung","conceptCode":"C12468","definition":"One of a pair of viscera occupying the pulmonary cavities of the thorax, the organs of respiration in which aeration of the blood takes place. As a rule, the right lung is slightly larger than the left and is divided into three lobes (an upper, a middle, and a lower or basal), while the left has two lobes (an upper and a lower or basal). Each lung is irregularly conical in shape, presenting a blunt upper extremity (the apex), a concave base following the curve of the diaphragm, an outer convex surface (costal surface), an inner or mediastinal surface (mediastinal surface), a thin and sharp anterior border, and a thick and rounded posterior border.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2351E2EE-473F-B747-E050-BB89AD430EFA","latestVersionIndicator":"Yes","beginDate":"2015-10-30","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2015-10-30","modifiedBy":"ONEDATA","dateModified":"2015-10-30","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2192548","version":"1","preferredName":"Involvement","preferredDefinition":"To have a connection by participation or association or use; sharing in an activity or process.","longName":"C25548","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Involvement","conceptCode":"C25548","definition":"To have a connection by participation or association or use; sharing in an activity or process.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"E9F4C3B9-9218-0989-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-11-29","endDate":null,"createdBy":"REEVESD","dateCreated":"2004-11-29","modifiedBy":"DATA_LOADER","dateModified":"2005-10-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2435022","version":"1","preferredName":"Disease, Disorder or Finding","preferredDefinition":"Specification of human conditions relevant to cancer. This includes observations, test results, history, and other concepts relevant to characterization of human cancer-related conditions. Non-neoplastic conditions of interest are also included.","longName":"C7057","context":"NCIP","contextVersion":"1","origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0741B16D-87D9-26CD-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-06","endDate":null,"createdBy":"CURTIST","dateCreated":"2005-12-06","modifiedBy":"SBR","dateModified":"2006-12-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"2351E2EE-474D-B747-E050-BB89AD430EFA","latestVersionIndicator":"Yes","beginDate":"2015-10-30","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2015-10-30","modifiedBy":"COOPERM","dateModified":"2016-12-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"5579080","version":"1","preferredName":"Chronic Graft Versus Host Disease Final Lung NIH Score","preferredDefinition":"A number or range of numeric values measuring performance, function, quality, or ability.","longName":"FINAL_LUNG_SCR","context":"CCR","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"7","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Score 3","valueDescription":"Score 3","ValueMeaning":{"publicId":"5589144","version":"1","preferredName":"Score 3","longName":"5589144","preferredDefinition":"FEV1 is less than or equal to 39 percent and lung symptoms are none to severe.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"GvHD Final Lung Score 3","conceptCode":"C131048","definition":"FEV1 is less than or equal to 39 percent and lung symptoms are none to severe.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"42E9C672-EED2-78D9-E053-F662850AB53F","latestVersionIndicator":"Yes","beginDate":"2016-12-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-12-05","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"42E9C672-EEEA-78D9-E053-F662850AB53F","beginDate":"2016-12-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-12-05","modifiedBy":"ONEDATA","dateModified":"2016-12-05","deletedIndicator":"No"},{"value":"Score 2","valueDescription":"Score 2","ValueMeaning":{"publicId":"5589145","version":"1","preferredName":"Score 2","longName":"5589145","preferredDefinition":"FEV1 is 40 to 59 percent and lung symptoms are none to moderate.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"GvHD Final Lung Score 2","conceptCode":"C131047","definition":"FEV1 is 40 to 59 percent and lung symptoms are none to moderate.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"42E9C672-EEF5-78D9-E053-F662850AB53F","latestVersionIndicator":"Yes","beginDate":"2016-12-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-12-05","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"42E9C672-EF0D-78D9-E053-F662850AB53F","beginDate":"2016-12-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-12-05","modifiedBy":"ONEDATA","dateModified":"2016-12-05","deletedIndicator":"No"},{"value":"Score 1","valueDescription":"Score 1","ValueMeaning":{"publicId":"5589146","version":"1","preferredName":"Score 1","longName":"5589146","preferredDefinition":"FEV1 is 60 to 79 percent and lung symptoms are none or mild.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"GvHD Final Lung Score 1","conceptCode":"C131045","definition":"FEV1 is 60 to 79 percent and lung symptoms are none or mild.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"42E9C672-EF18-78D9-E053-F662850AB53F","latestVersionIndicator":"Yes","beginDate":"2016-12-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-12-05","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"42E9C672-EF30-78D9-E053-F662850AB53F","beginDate":"2016-12-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-12-05","modifiedBy":"ONEDATA","dateModified":"2016-12-05","deletedIndicator":"No"},{"value":"Score 0","valueDescription":"Score 0","ValueMeaning":{"publicId":"5589147","version":"1","preferredName":"Score 0","longName":"5589147","preferredDefinition":"FEV1 is greater than or equal to 80 percent with or without lung symptoms.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"GvHD Final Lung Score 0","conceptCode":"C131044","definition":"FEV1 is greater than or equal to 80 percent with or without lung symptoms.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"42E9C672-EF3B-78D9-E053-F662850AB53F","latestVersionIndicator":"Yes","beginDate":"2016-12-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-12-05","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"42E9C672-EF53-78D9-E053-F662850AB53F","beginDate":"2016-12-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-12-05","modifiedBy":"ONEDATA","dateModified":"2016-12-05","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008556","version":"1","preferredName":"Assessment Results","preferredDefinition":"the results of evaluations of the patient and the patient's disease.","longName":"ASSESS_RESULTS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B2D08DE9-38BB-7208-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-27","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-27","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2193207","version":"1","preferredName":"Score","preferredDefinition":"A number or range of numeric values measuring performance, function, quality, or ability.","longName":"C25338","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Score","conceptCode":"C25338","definition":"A number or range of numeric values measuring performance, function, quality, or ability.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"EACFDBFA-EFD4-25E6-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-12-09","endDate":null,"createdBy":"MAESKEB","dateCreated":"2004-12-09","modifiedBy":"DATA_LOADER","dateModified":"2005-10-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"C3D:Central Cancer Clinical Database","workflowStatus":"RELEASED","registrationStatus":"Application","id":"4197E66F-D7AB-20E1-E053-F662850A7D4E","latestVersionIndicator":"Yes","beginDate":"2016-11-18","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-11-18","modifiedBy":"COOPERM","dateModified":"2016-12-21","changeDescription":"Created for NIH Score CRF as requested by Y. Yakovlev. mc 11/18/16","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2008601","version":"1","longName":"C3D Domain","context":"CCR","ClassificationSchemeItems":[{"publicId":"2811685","version":"1","longName":"CCR","context":"CCR"}]},{"publicId":"2182125","version":"1","longName":"CCR Implementation","context":"CCR","ClassificationSchemeItems":[{"publicId":"2811673","version":"1","longName":"C3D","context":"CCR"}]}],"AlternateNames":[],"ReferenceDocuments":[{"name":"Final GVHD Lung Score","type":"Preferred Question Text","description":"Final GVHD Lung Score","url":null,"context":"CCR"}],"origin":"C3D:Central Cancer Clinical Database","workflowStatus":"RELEASED","registrationStatus":"Application","id":"41C36DC8-6369-6402-E053-F662850A7925","latestVersionIndicator":"Yes","beginDate":"2016-11-20","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-11-20","modifiedBy":"COOPERM","dateModified":"2016-12-06","changeDescription":"Created for NIH Score CRF as requested by Y. Yakovlev. mc 11/18/16","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}